RESUMO
Aliphatic polyesters are the most common type of biodegradable synthetic polymer used in many pharmaceutical applications nowadays. This report describes the ring-opening polymerization (ROP) of l-lactide (L-LA), ε-caprolactone (CL) and glycolide (Gly) in the presence of a simple, inexpensive and convenient PEG200-BiOct3 catalytic system. The chemical structures of the obtained copolymers were characterized by 1H- or 13C-NMR. GPC was used to estimate the average molecular weight of the resulting polyesters, whereas TGA and DSC were employed to determine the thermal properties of polymeric products. The effects of temperature, reaction time, and catalyst content on the polymerization process were investigated. Importantly, the obtained polyesters were not cyto- or genotoxic, which is significant in terms of the potential for medical applications (e.g., for drug delivery systems). As a result of transesterification, the copolymers obtained had a random distribution of comonomer units along the polymer chain. The thermal analysis indicated an amorphous nature of poly(l-lactide-co-ε-caprolactone) (PLACL) and a low degree of crystallinity of poly(ε-caprolactone-co-glycolide) (PCLGA, Xc = 15.1%), in accordance with the microstructures with random distributions and short sequences of comonomer units (l = 1.02-2.82). Significant differences in reactivity were observed among comonomers, confirming preferential ring opening of L-LA during the copolymerization process.
Assuntos
Bismuto/química , Caproatos/química , Dioxanos/química , Lactonas/química , Ácido Poliglicólico/química , Polimerização , Caproatos/síntese química , Catálise , Dioxanos/síntese química , Lactonas/síntese química , Poliésteres/síntese química , Poliésteres/química , Ácido Poliglicólico/síntese química , TemperaturaRESUMO
Ergosterol exert the important function in maintaining the fluidity and osmotic pressure of fungal cells, and its key biosynthesis enzymes (Squalene epoxidase, SE; 14 α-demethylase, CYP51) displayed the obvious synergistic effects. Therefore, we expected to discover the novel antifungal compounds with dual-target (SE/CYP51) inhibitory activity. In the progress, we screened the different kinds of potent fragments based on the dual-target (CYP51, SE) features, and the method of fragment-based drug discovery (FBDD) was used to guide the construction of three different series of benzodioxane compounds. Subsequently, their chemical structures were synthesized and evaluated. These compounds displayed the obvious biological activity against the pathogenic fungal strains. Notably, target compounds 10a-2 and 22a-2 possessed the excellent broad-spectrum anti-fungal activity (MIC50, 0.125-2.0 µg/mL) and the activity against drug-resistant strains (MIC50, 0.5-2.0 µg/mL). Preliminary mechanism studies have confirmed that these compounds effectively inhibited the dual-target (SE/CYP51) activity, they could cause fungal rupture and death by blocking the bio-synthetic pathway of ergosterol. Further experiments discovered that compounds 10a-2 and 22a-2 also maintained a certain of anti-fungal effect in vivo. In summary, this study not only provided the new dual-target drug design strategy and method, but also discover the potential antifungal compounds.
Assuntos
Inibidores de 14-alfa Desmetilase/farmacologia , Antifúngicos/farmacologia , Derivados de Benzeno/farmacologia , Candida/efeitos dos fármacos , Dioxanos/farmacologia , Esterol 14-Desmetilase/metabolismo , Inibidores de 14-alfa Desmetilase/síntese química , Inibidores de 14-alfa Desmetilase/química , Antifúngicos/síntese química , Antifúngicos/química , Derivados de Benzeno/síntese química , Derivados de Benzeno/química , Candida/metabolismo , Dioxanos/síntese química , Dioxanos/química , Relação Dose-Resposta a Droga , Testes de Sensibilidade Microbiana , Modelos Moleculares , Estrutura Molecular , Relação Estrutura-AtividadeRESUMO
Novel bacterial topoisomerase inhibitors (NBTIs) are among the most promising new antibiotics in preclinical/clinical development. We previously reported dioxane-linked NBTIs with potent antistaphylococcal activity and reduced hERG inhibition, a key safety liability. Herein, polarity-focused optimization enabled the delineation of clear structure-property relationships for both microsomal metabolic stability and hERG inhibition, resulting in the identification of lead compound 79. This molecule demonstrates potent antibacterial activity against diverse Gram-positive pathogens, inhibition of both DNA gyrase and topoisomerase IV, a low frequency of resistance, a favorable in vitro cardiovascular safety profile, and in vivo efficacy in a murine model of methicillin-resistant Staphylococcus aureus infection.
Assuntos
Antibacterianos/farmacologia , Dioxanos/farmacologia , Inibidores Enzimáticos/farmacologia , Canais de Potássio Éter-A-Go-Go/antagonistas & inibidores , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Antibacterianos/síntese química , Antibacterianos/química , DNA Girase/metabolismo , DNA Topoisomerase IV/antagonistas & inibidores , DNA Topoisomerase IV/metabolismo , Dioxanos/síntese química , Dioxanos/química , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Canais de Potássio Éter-A-Go-Go/metabolismo , Humanos , Testes de Sensibilidade Microbiana , Estrutura Molecular , Relação Estrutura-AtividadeRESUMO
Biodegradable anastomat play an important role in the reconstruction process of the digestive tract. However, the biocompatibility and organizational compliance of anastomotic tubes still need to be improved. Electrospun tissue engineering scaffolds have excellent biomimetic extracellular matrix properties, biocompatibility and biodegradability. In the present study, electrospun poly(trimethylene carbonate) (PTMC) intestinal anastomosis scaffolds loaded with triclosan (TCS) were reported to reduce the probability of intestinal fistula and obstruction. When the viscosity average molecular weight of PTMC was 157 × 103, the elastic modulus and tensile strength of the anastomosis scaffolds could reach 20.11 MPa and 16.08 MPa, respectively, which indicated that the anastomosis scaffolds exhibited excellent tensile flexibility. The degradation of PTMC was accelerated with the increase of Mw. After 28 days, the weight and length of the anastomosis scaffolds reduced 40% and 50%, respectively. Furthermore, the application of PTMC anastomosis scaffolds could promote intestinal healing and reduce the probability of intestinal fistula and obstruction.
Assuntos
Materiais Biocompatíveis/química , Dioxanos/química , Fístula Intestinal/cirurgia , Obstrução Intestinal , Polímeros/química , Alicerces Teciduais/química , Anastomose Cirúrgica , Animais , Materiais Biocompatíveis/síntese química , Dioxanos/síntese química , Teste de Materiais , Polímeros/síntese química , Ratos , Ratos Sprague-Dawley , Engenharia TecidualRESUMO
The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health. Vaccines are ideal solutions to prevent infection, but treatments are also needed for those who have contracted the virus to limit negative outcomes, when vaccines are not applicable. Viruses must cross host cell membranes during their life cycle, creating a dependency on processes involving membrane dynamics. Thus, in this study, we examined whether the synthetic machinery for glycosphingolipids, biologically active components of cell membranes, can serve as a therapeutic target to combat SARS-CoV-2. We examined the antiviral effect of two specific inhibitors of glucosylceramide synthase (GCS): (i) Genz-123346, an analogue of the United States Food and Drug Administration-approved drug Cerdelga and (ii) GENZ-667161, an analogue of venglustat, which is currently under phase III clinical trials. We found that both GCS inhibitors inhibit replication of SARS-CoV-2. Moreover, these inhibitors also disrupt replication of influenza virus A/PR/8/34 (H1N1). Our data imply that synthesis of glycosphingolipids is necessary to support viral life cycles and suggest that GCS inhibitors should be further explored as antiviral therapies.
Assuntos
Antivirais/farmacologia , Carbamatos/farmacologia , Dioxanos/farmacologia , Glucosiltransferases/antagonistas & inibidores , Glicoesfingolipídeos/antagonistas & inibidores , Vírus da Influenza A Subtipo H1N1/efeitos dos fármacos , Pirrolidinas/farmacologia , Quinuclidinas/farmacologia , SARS-CoV-2/efeitos dos fármacos , Animais , Antivirais/síntese química , COVID-19/enzimologia , COVID-19/virologia , Carbamatos/síntese química , Membrana Celular/efeitos dos fármacos , Membrana Celular/enzimologia , Membrana Celular/virologia , Chlorocebus aethiops , Ensaios Clínicos Fase III como Assunto , Dioxanos/síntese química , Cães , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/farmacologia , Regulação da Expressão Gênica , Glucosiltransferases/genética , Glucosiltransferases/metabolismo , Glicoesfingolipídeos/biossíntese , Interações Hospedeiro-Patógeno/genética , Humanos , Vírus da Influenza A Subtipo H1N1/crescimento & desenvolvimento , Vírus da Influenza A Subtipo H1N1/metabolismo , Influenza Humana/tratamento farmacológico , Influenza Humana/enzimologia , Influenza Humana/virologia , Células Madin Darby de Rim Canino , Pirrolidinas/síntese química , Quinuclidinas/síntese química , SARS-CoV-2/crescimento & desenvolvimento , SARS-CoV-2/metabolismo , Transdução de Sinais , Células Vero , Replicação Viral/efeitos dos fármacos , Tratamento Farmacológico da COVID-19RESUMO
A series of diastereomeric 2-(2-pyrrolidinyl)-1,4-benzodioxanes bearing a small, hydrogen-bonding substituent at the 7-, 6-, or 5-position of benzodioxane have been studied for α4ß2 and α3ß4 nicotinic acetylcholine receptor affinity and activity. Analogous to C(5)H replacement with N and to a much greater extent than decoration at C(7), substitution at benzodioxane C(5) confers very high α4ß2/α3ß4 selectivity to the α4ß2 partial agonism. Docking into the two receptor structures recently determined by cryo-electron microscopy and site-directed mutagenesis at the minus ß2 side converge in indicating that the limited accommodation capacity of the ß2 pocket, compared to that of the ß4 pocket, makes substitution at C(5) rather than at more projecting C(7) position determinant for this pursued subtype selectivity.
Assuntos
Dioxanos/química , Agonistas Nicotínicos/química , Receptores Nicotínicos/química , Sítios de Ligação , Microscopia Crioeletrônica , Dioxanos/síntese química , Dioxanos/metabolismo , Humanos , Ligação de Hidrogênio , Simulação de Acoplamento Molecular , Mutagênese Sítio-Dirigida , Agonistas Nicotínicos/síntese química , Agonistas Nicotínicos/metabolismo , Antagonistas Nicotínicos/química , Antagonistas Nicotínicos/metabolismo , Pirrolidinas/química , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Estereoisomerismo , Relação Estrutura-AtividadeRESUMO
We compared in vitro degradation and physical properties of polypropylene and a biodegradable polymer synthesized by electrospinning and consisting of 65% polycaprolactone and 35% polytrimethylene carbonate as a possible alternative material for use in surgery for pelvic floor muscle failure. Samples of the studied polymers were implanted to 10 male Wistar rats into the interfascial space on the back (polypropylene on the right side and biodegradable polymer on the left side). The synthesized biopolymer was characterized by elongation and tear resistance, similar to those of polypropylene. During the period from the third to the sixth month after implantation, the area of fibrosis around individual polypropylene and biopolymer fibers increased by 16.7 and 107.9%, respectively, while remaining reduced compared to polypropylene. The total fibrosis area in 6 months after implantation of polypropylene and biopolymer samples significantly increased by 18% (p=0.0097) and 48% (p=0.05), respectively, i.e. fibrosing processes were more intense in case of biopolymer. Induction of more pronounced fibrosis can be an advantage of the synthesized biopolymer when choosing the material for fabrication of implants and their use for correction of incompetence of the ligamentous and muscular apparatus.
Assuntos
Implantes Absorvíveis , Materiais Biocompatíveis/metabolismo , Dioxanos/metabolismo , Poliésteres/metabolismo , Polímeros/metabolismo , Polipropilenos/metabolismo , Telas Cirúrgicas , Animais , Materiais Biocompatíveis/síntese química , Materiais Biocompatíveis/farmacologia , Dioxanos/síntese química , Dioxanos/farmacologia , Fáscia/efeitos dos fármacos , Fáscia/ultraestrutura , Fibrose , Humanos , Interações Hidrofóbicas e Hidrofílicas , Masculino , Teste de Materiais , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/cirurgia , Músculo Esquelético/ultraestrutura , Poliésteres/síntese química , Poliésteres/farmacologia , Polímeros/síntese química , Polímeros/farmacologia , Polipropilenos/síntese química , Polipropilenos/farmacologia , Ratos , Ratos WistarRESUMO
Leishmaniases are neglected diseases that can be treated with a limited drug arsenal; the development of new molecules is therefore a priority. Recent evidence indicates that endoperoxides, including artemisinin and its derivatives, possess antileishmanial activity. Here, 1,2-dioxanes were synthesized with their corresponding tetrahydropyrans lacking the peroxide bridge, to ascertain if this group is a key pharmacophoric requirement for the antileishmanial bioactivity. Newly synthesized compounds were examined in vitro, and their mechanism of action was preliminarily investigated. Three endoperoxides and their corresponding tetrahydropyrans effectively inhibited the growth of Leishmania donovani promastigotes and amastigotes, and iron did not play a significant role in their activation. Further, reactive oxygen species were produced in both endoperoxide- and tetrahydropyran-treated promastigotes. In conclusion, the peroxide group proved not to be crucial for the antileishmanial bioactivity of endoperoxides, under the tested conditions. Our findings reveal the potential of both 1,2-dioxanes and tetrahydropyrans as lead compounds for novel therapies against Leishmania.
Assuntos
Antiprotozoários/farmacologia , Dioxanos/química , Leishmania donovani/efeitos dos fármacos , Piranos/química , Animais , Antiprotozoários/síntese química , Antiprotozoários/química , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Chlorocebus aethiops , Cristalografia por Raios X , Dioxanos/síntese química , Dioxanos/farmacologia , Desenho de Fármacos , Humanos , Quelantes de Ferro/farmacologia , Leishmania donovani/fisiologia , Estágios do Ciclo de Vida/efeitos dos fármacos , Conformação Molecular , Piranos/síntese química , Piranos/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Células VeroRESUMO
The C5-C6 nerve roots are usually spared from avulsion after brachial plexus injury (BPI) and can thus be used as donors for nerve repair. A BPI rat model with C5-C6 nerve root stumps has been established in our previous work. The aim of this study was to test whether riluzole loaded into a thermosensitive hydrogel could applied locally in the nerve root stumps of this BPI rat model, thus increasing the reparative effect of the nerve root stumps. Nile red (a hydrophobic dye) was used as a substitute for riluzole since riluzole itself does not emit light. Nile red, loaded into a thermosensitive hydrogel, was added to the nerve root stumps of the BPI rat model. Additionally, eighteen rats, with operation on right brachial plexus, were evenly divided into three groups: control (Con), thermosensitive hydrogel (Gel) and thermosensitive hydrogel loaded with riluzole (Gel + Ri) groups. Direct nerve repair was performed after local riluzole release for two weeks. Functional and electrophysiological evaluations and histological assessments were used to evaluate the reparative effect 8 weeks after nerve repair. Nile red was slowly released from the thermosensitive hydrogel and retrograde transport through the nerve root stumps to the motoneurons, according to immunofluorescence. Discernible functional recovery began earlier in the Gel + Ri group. The compound muscle action potential, ChAT-expressing motoneurons, positivity for neurofilaments and S100, diameter of regenerating axons, myelin sheath thickness and density of myelinated fibers were markedly increased in the Gel + Ri group compared with the Con and Gel groups. Our results indicate that the local administration of riluzole could undergo retrograde transportation through C5-C6 nerve root stumps, thereby promoting neuroprotection and increasing nerve regeneration.
Assuntos
Neuropatias do Plexo Braquial/tratamento farmacológico , Hidrogéis/química , Neurônios Motores/efeitos dos fármacos , Fármacos Neuroprotetores/uso terapêutico , Riluzol/uso terapêutico , Raízes Nervosas Espinhais/efeitos dos fármacos , Animais , Plexo Braquial/patologia , Plexo Braquial/cirurgia , Neuropatias do Plexo Braquial/patologia , Dioxanos/síntese química , Dioxanos/química , Sistemas de Liberação de Medicamentos , Liberação Controlada de Fármacos , Feminino , Hidrogéis/síntese química , Regeneração Nervosa/efeitos dos fármacos , Poloxâmero/síntese química , Poloxâmero/química , Polímeros/síntese química , Polímeros/química , Ratos Sprague-Dawley , Raízes Nervosas Espinhais/patologiaRESUMO
Enthalpies of combustion of 2,2-trans-4,6- (1) and 4,4,6,6-tetramethyl- (2) and 2,4,4,6,6- (3) and 2,2,4,4,6-pentamethyl-1,3-dioxanes (4) were determined to estimate their enthalpies of formation in the gas phase. By comparing the latter with the corresponding enthalpies estimated based on the various bond-bond interactions allowed to determine the chair-2,5-twist energy difference (ΔHCT = 29.8 kJ mol-1) for 1 since C-13 shift correlations indicate that it escapes to the 2,5-twist form where the 2-methyl groups are isoclinal and 4- and 6-methyl groups pseudoequatorial to avoid syn-axial interactions. Compounds 2 and 3 in turn give the values 21.0 and 21.6 kJ mol-1 for the 4,6-diaxial Me,Me-interaction. Finally compound 4, which retains the chair conformation to avoid pseudoaxial interactions in the twist forms gives the value 19.5 kJ mol-1 for the 2,4-diaxial Me,Me-interaction indicating that its chair form appears to be somewhat deformed.
Assuntos
Dioxanos/química , Dioxanos/síntese química , Conformação Molecular , Estrutura Molecular , Fenômenos Físicos , Estereoisomerismo , TermodinâmicaRESUMO
Commercially available strontium isopropoxide represents a suitable catalyst/initiator for the ring-opening polymerization (ROP) of lactide (LA), ε-caprolactone, δ-valerolactone, δ-caprolactone, and δ-decalactone. Well-defined polyesters are accessible via the solution polymerization of lactide in toluene with a [LA]:[Sr] ratio of 100:1 at room temperature with or without the addition of dodecanol as coinitiator. Kinetic studies and detailed analysis by means of matrix-assisted laser desorption ionization mass spectrometry reveal pseudo-first-order kinetics of the ROP as well as excellent endgroup fidelity of the polylactide (PLA) with isopropyl and dodecyl α-endgroups. Both isopropanolate moieties as well as the coinitiator each initiate PLA chains, enabling the synthesis of PLA with tailored molar mass. The polymerization of ε-caprolactone and δ-valerolactone confirms the high catalyst activity, which causes quantitative monomer conversion after 1 min polymerization time but broad molar mass distributions. In contrast, the catalyst is well suited for the ROP of the less reactive δ-caprolactone and δ-decalactone. Although kinetic studies reveal initially bimodal molar mass distributions, polyesters with dispersity values Ð < 1.2 and unimodal molar mass distributions can be obtained at moderate to high monomer conversions.
Assuntos
Dioxanos/química , Lactonas/química , Óxidos/química , Polimerização , Estrôncio/química , Catálise , Dioxanos/síntese química , Cinética , Lactonas/síntese química , Poliésteres/síntese química , Poliésteres/químicaRESUMO
A series of compounds generated by ring expansion/opening and molecular elongation/simplification of the 1,3-dioxolane scaffold were prepared and tested for binding affinity at 5-HT1AR and α1 adrenoceptors. The compounds with greater affinity were selected for further functional studies. N-((2,2-diphenyl-1,3-dioxan-5-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-ammonium hydrogen oxalate (12) emerged as highly potent full agonist at the 5-HT1AR (pKi 5-HT1Aâ¯=â¯8.8; pD2â¯=â¯9.22, %Emaxâ¯=â¯92). The pharmacokinetic data in rats showed that the orally administered 12 has a high biodistribution in the brain compartment. Thus, 12 was further investigated in-vivo, showing an anxiolytic and antidepressant effect. Moreover, in the formalin test, 12 was able to decrease the late response to the noxious stimulus, indicating a potential use in the treatment of chronic pain.
Assuntos
Analgésicos/uso terapêutico , Ansiolíticos/uso terapêutico , Antidepressivos/uso terapêutico , Dioxanos/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Agonistas do Receptor 5-HT1 de Serotonina/uso terapêutico , Analgésicos/síntese química , Analgésicos/farmacocinética , Analgésicos/toxicidade , Animais , Ansiolíticos/síntese química , Ansiolíticos/farmacocinética , Ansiolíticos/toxicidade , Antidepressivos/síntese química , Antidepressivos/farmacocinética , Antidepressivos/toxicidade , Encéfalo/metabolismo , Dioxanos/síntese química , Dioxanos/farmacocinética , Dioxanos/toxicidade , Masculino , Fármacos Neuroprotetores/síntese química , Fármacos Neuroprotetores/farmacocinética , Fármacos Neuroprotetores/toxicidade , Ratos Sprague-Dawley , Receptor 5-HT1A de Serotonina/metabolismo , Receptores Adrenérgicos alfa 1/metabolismo , Agonistas do Receptor 5-HT1 de Serotonina/síntese química , Agonistas do Receptor 5-HT1 de Serotonina/farmacocinética , Agonistas do Receptor 5-HT1 de Serotonina/toxicidade , Estereoisomerismo , Relação Estrutura-AtividadeRESUMO
Both c-Met and VEGFR-2 were important targets for cancer therapies. In order to develop reversible and non-covalent c-Met and VEGFR-2 dual inhibitors, a series of [1,4]dioxino[2,3-f]quinazoline derivatives were designed and synthesized. The enzyme assay demonstrated that most target compounds had inhibition potency on both c-Met and VEGFR-2 with IC50 values in nanomolar range especially compounds 7m and 7k. Based on further cell proliferation assay in vitro, compound 7k showed significantly anti-tumor activity in vivo on a hepatocellular carcinoma (MHCC97H cells) xenograft mouse model. We docked the compound 7m with c-Met and VEGFR-2 kinases, and interpreted the SAR of these analogues. All results indicated that the target compounds were dual inhibitors of c-Met and VEGFR-2 kinases that held promising potential in cancer therapy.
Assuntos
Antineoplásicos/uso terapêutico , Dioxanos/uso terapêutico , Neoplasias/tratamento farmacológico , Proteínas Proto-Oncogênicas c-met/antagonistas & inibidores , Quinazolinas/uso terapêutico , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/antagonistas & inibidores , Animais , Antineoplásicos/síntese química , Antineoplásicos/metabolismo , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Dioxanos/síntese química , Dioxanos/metabolismo , Feminino , Humanos , Ligação de Hidrogênio , Camundongos SCID , Simulação de Acoplamento Molecular , Estrutura Molecular , Proteínas Proto-Oncogênicas c-met/metabolismo , Quinazolinas/síntese química , Quinazolinas/metabolismo , Relação Estrutura-Atividade , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/metabolismo , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
The treatment of human leishmaniasis is currently based on few compounds that are highly toxic, expensive and have a high rate of treatment failure. A number of recent studies on new drugs focuses on natural or semi-synthetic compounds. Among them, the endoperoxide artemisinin, extracted from Artemisia annua, and some of its derivatives have shown leishmanicidal activity. In the present work, a series of structurally simple, fully synthetic 1,2-dioxanes were evaluated for in vitro antileishmanial activity against promastigotes of Leishmania donovani; the cytotoxicity for mammalian cells was also assessed. The six most promising compounds in terms of activity and selectivity were further investigated for their antileishmanial activity on the promastigote forms of L. tropica, L. major and L. infantum and against L. donovani amastigotes. The good performance in terms of potency and selectivity makes these six hits promising candidates for a preliminary lead optimization as antileishmanial agents.
Assuntos
Dioxanos/química , Dioxanos/farmacologia , Leishmania/efeitos dos fármacos , Leishmaniose/tratamento farmacológico , Tripanossomicidas/química , Tripanossomicidas/farmacologia , Animais , Chlorocebus aethiops , Dioxanos/síntese química , Desenho de Fármacos , Humanos , Testes de Sensibilidade Parasitária , Células VeroRESUMO
A series of derivatives obtained by moving the aromatic moiety on the 1,4-dioxane ring of compounds 1-3 from position 6 to position 2 or 3 was prepared and evaluated for the affinity for 5-HT1A receptor (5-HT1AR) and α1-adrenoceptor (α1-AR) subtypes. Moreover, the flexible 2-ethanolamine linker of the most interesting compounds was replaced by the more conformationally constrained piperazine ring. In vitro functional studies performed on derivatives showing the highest affinities for 5-HT1AR highlighted that the shifting of the diphenyl moiety of derivatives 2 and 13 from position 6 to position 3 of the 1,4-dioxane nucleus, affording 11 and 16, respectively, modulated the 5-HT1AR functional profile from agonism to antagonism. Docking simulations, performed on the human 5-HT1AR, further rationalized the biological results, delving into the features which modulate the shift between agonist and antagonist activity. Interestingly, compound 11, endowed with mixed 5-HT1AR/α1d-AR antagonist profile, showed antiproliferative and cytotoxic effects on both PC-3 and DU-145 prostate cancer cell lines higher than those of the α1d-AR antagonist 2 and the 5-HT1AR antagonist 16. The experiments performed in the presence of the endogenous agonists norepinephrine and serotonin confirmed the involvement of both receptor systems in the antitumor activity of 11.
Assuntos
Antineoplásicos/farmacologia , Dioxanos/farmacologia , Neoplasias da Próstata/tratamento farmacológico , Receptor 5-HT1A de Serotonina/metabolismo , Antineoplásicos/síntese química , Antineoplásicos/química , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Dioxanos/síntese química , Dioxanos/química , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Masculino , Modelos Moleculares , Estrutura Molecular , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/patologia , Relação Estrutura-AtividadeRESUMO
FFA1 (free fatty acid receptor 1) has emerged as an attractive antidiabetic target due to its role in mediating the enhancement of glucose-stimulated insulin secretion in pancreatic ß cells with a low risk of hypoglycemia. Many reported FFA1 agonists possessed somewhat pharmacokinetic and/or safety issues. Herein, we describe the identification of 2,3-dihydrobenzo[b][1,4]dioxine as a novel scaffold for FFA1 agonists. Comprehensive structure-activity relationship study based on this scaffold led to the discovery of (S)-3-(4-(((S)-7-(4-methoxyphenyl)-2,3-dihydrobenzo [b][1,4]dioxin-2-yl)methoxy) phenyl)hex-4-ynoic acid (26k), which displayed a potent FFA1 agonistic activity and good pharmacokinetic profiles. Subsequent in vivo studies demonstrated that compound 26k significantly improved the glucose tolerance in ICR mice. In summary, compound 26k is a promising drug candidate for further investigation.
Assuntos
Dioxanos/farmacologia , Hipoglicemiantes/farmacologia , Receptores Acoplados a Proteínas G/agonistas , Animais , Glicemia/efeitos dos fármacos , Dioxanos/síntese química , Dioxanos/farmacocinética , Células HEK293 , Humanos , Hipoglicemiantes/síntese química , Hipoglicemiantes/farmacocinética , Masculino , Camundongos Endogâmicos ICR , Estrutura Molecular , Ratos Sprague-Dawley , Relação Estrutura-AtividadeRESUMO
Enhancing endogenous cannabinoid (eCB) signaling has been considered as a potential strategy for the treatment of stress-related conditions. Fatty acid amide hydrolase (FAAH) represents the primary degradation enzyme of the eCB anandamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA). This study describes a potent reversible FAAH inhibitor, SSR411298. The drug acts as a selective inhibitor of FAAH, which potently increases hippocampal levels of AEA, OEA and PEA in mice. Despite elevating eCB levels, SSR411298 did not mimic the interoceptive state or produce the behavioral side-effects (memory deficit and motor impairment) evoked by direct-acting cannabinoids. When SSR411298 was tested in models of anxiety, it only exerted clear anxiolytic-like effects under highly aversive conditions following exposure to a traumatic event, such as in the mouse defense test battery and social defeat procedure. Results from experiments in models of depression showed that SSR411298 produced robust antidepressant-like activity in the rat forced-swimming test and in the mouse chronic mild stress model, restoring notably the development of inadequate coping responses to chronic stress. This preclinical profile positions SSR411298 as a promising drug candidate to treat diseases such as post-traumatic stress disorder, which involves the development of maladaptive behaviors.
Assuntos
Amidoidrolases/antagonistas & inibidores , Ansiolíticos/farmacologia , Transtornos de Ansiedade/tratamento farmacológico , Agonistas de Receptores de Canabinoides/metabolismo , Carbamatos/farmacologia , Dioxanos/farmacologia , Inibidores Enzimáticos/farmacologia , Receptores de Canabinoides/genética , Estresse Psicológico/tratamento farmacológico , Doença Aguda , Amidas , Amidoidrolases/genética , Amidoidrolases/metabolismo , Animais , Ansiolíticos/síntese química , Transtornos de Ansiedade/fisiopatologia , Ácidos Araquidônicos/metabolismo , Carbamatos/síntese química , Doença Crônica , Dioxanos/síntese química , Endocanabinoides/metabolismo , Inibidores Enzimáticos/síntese química , Etanolaminas/metabolismo , Feminino , Expressão Gênica , Masculino , Camundongos , Ácidos Oleicos/metabolismo , Ácidos Palmíticos/metabolismo , Alcamidas Poli-Insaturadas/metabolismo , Ratos Sprague-Dawley , Receptores de Canabinoides/metabolismo , Estresse Psicológico/fisiopatologiaRESUMO
Inexorably, the environmental persistence and damage caused by polyolefins have become major drawbacks to their continued long-term use. Global shifts in thinking from fossil-fuel to renewable biobased resources have urged researchers to focus their attention on substituting fossil-fuel based polymers with renewable and biodegradable alternatives on an industrial scale. The recent development of biodegradable polyesters from ring opening polymerization (ROP) of bioderived cyclic ester monomers has emerged as a promising new avenue toward this goal. Ever increasing numbers of metal-based initiators have been reported in the literature for the controlled ROP of cyclic esters, in particular for the polymerization of lactide to produce poly(lactic acid) (PLA). PLA has several material weaknesses, which hinder its use as a replacement for commodity plastics. Despite many advances in developing highly active and controlled catalysts for lactide polymerization, no single catalyst system has emerged to replace industrially used catalysts and provide access to PLA materials with improved properties. We reported the first example of indium(III) for the ring opening polymerization of lactide. Since then, indium(III) has emerged as a useful Lewis acid in initiators for the controlled polymerization of lactide and other cyclic esters. In particular, we have developed a large family of chiral dinuclear indium complexes bearing tridentate diaminophenolate ligands and tetradentate salen and salan ligands. Complexes within our tridentate ligand family are highly active initiators for the moderately isoselective living and immortal polymerization of rac-lactide, as well as other cyclic esters. We have shown that subtle steric effects influence aggregation in these systems, with polymerization typically proceeding through a dinuclear propagating species. In addition, profound effects on polymerization activities have been observed for central tertiary versus secondary amine donors in these and other related systems. In contrast, our well-controlled and highly active chiral indium salen systems are more isoselective than the tridentate analogues and polymerize lactide via a mononuclear propagating species. Again, we have noticed that subtle steric and electronic changes to the ligand can influence both polymerization activity and stereoselectivity via aggregation phenomena. Recently, we have reported a promising new chiral indium catalyst supported by a tetradentate salan ligand. This catalyst is remarkably water and air stable and can be activated by linear and branched alcohols to provide controlled access to multiblock copolymers in air. This catalyst represents an important step forward toward generating new, commercially relevant catalysts for ROP of cyclic esters to produce novel biodegradable polymers, and highlights the unique value of indium-based catalysts in the field.
Assuntos
Dioxanos/síntese química , Ésteres/síntese química , Índio/química , Catálise , Dioxanos/química , Ésteres/química , Estrutura Molecular , PolimerizaçãoRESUMO
Although the copolymerizations of l-lactide (LA) with seven- or six-membered ring lactones have been extensively studied, the copolymerizations of LA with four-membered ring lactones have scarcely been reported. In this work, we studied the copolymerization of LA with ß-propiolactone (PL) and the properties of the obtained copolymers. The copolymerization of LA with PL was carried out using trifluoromethanesulfonic acid as a catalyst and methanol as an initiator to produce poly(LA-co-PL) with Mn of ~50,000 and PL-content of 6-67 mol %. The Tg values of the copolymers were rapidly lowered with increasing PL-contents. The Tm and ΔHm of the copolymers gradually decreased with increasing PL-contents, indicating their decreased crystallinity. Biodegradation test of the copolymers in compost demonstrated their improved biodegradability in comparison with the homopolymer of LA.
Assuntos
Biodegradação Ambiental , Dioxanos/síntese química , Dioxanos/metabolismo , Polímeros/síntese química , Polímeros/metabolismo , Propiolactona/síntese química , Propiolactona/metabolismo , Materiais Biocompatíveis/química , Materiais Biocompatíveis/metabolismo , Catálise , Lactonas/metabolismo , Teste de Materiais , Peso Molecular , Polimerização , Polímeros/química , TemperaturaRESUMO
To obtain novel muscarinic acetylcholine receptor (mAChR) antagonists, the enantiomers of the hybrid compounds 3-5, in which the quinuclidin-3-yloxy fragment of solifenacin and the 6,6-diphenyl-1,4-dioxane-2-yl moiety of 2 linked by an ester or ether spacer were embedded in the same chemical entity, were prepared and evaluated for their affinity at the five mAChR subtypes (M1-M5). Stereochemistry and the nature of the linker between the quinuclidine moiety and the 1,4-dioxane nucleus play an important role on the affinities of the compounds. The presence of an ether bridge confers higher affinities for all mAChR subtypes to the ligand. Interestingly, the ether enantiomer (R,S)-5 shows the highest affinity at all mAChR subtypes with pKi values similar to that of solifenacin at M3 and higher at the other subtypes. Unlike solifenacin, it shows a preference for M1 mAChR subtype with respect to the other subtypes. This compound, lacking a permanent positive charge on the nitrogen atom, can be a useful tool for the pharmacological study of mAChRs in the central nervous system.